Rezolute Provides Update on its Phase 3 sunRIZE Study of Ersodetug for the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism
Open-label arm (infant participants < 1 year old) has been recently reviewed by a Data Monitoring Committee (DMC) and target drug ...
Rezolute's ersodetug advances in pediatric study
REDWOOD CITY, Calif. - Rezolute , Inc. (NASDAQ:RZLT), a biopharmaceutical company with a market capitalization of $303.62 million and impressive recent momentum (up 13.91% in the past week), announced ...
Nature3y
60 Intensive Insulin Therapy and Brief Hypoglycemia Do Not Increase Markers of Neurological Injury in Critically Ill Children
Both hyperglycemia and hypoglycemia may adversely affect the developing brain in children. We studied the impact of targeting normoglycemia with IIT on circulating markers of brain injury in ...
Business Insider1mon
Rezolute Receives Breakthrough Therapy Designation from FDA for Ersodetug in the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism
About Congenital Hyperinsulinism Congenital hyperinsulinism (HI) is the most common cause of recurrent and persistent hypoglycemia in children. Patients with congenital HI typically present with ...
Healthline13d
Is Hypoglycemia a Common Symptom of Lupus?
Hypoglycemia (low blood sugar) is not a formal symptom of lupus, but it may develop from related factors like medication use, other autoimmune processes in the body, and hormonal changes. Lupus ...
The Scientist5y
Mysterious Illness Linked to Lychees Kills Children in India
The children had hypoglycemia, or low blood sugar, and symptoms of acute encephalopathy syndrome, which leads to inflammation of the brain and results in fever and disorientation or delirium.
Healthline10d
Baqsimi: Pregnancy and Breastfeeding Information
Baqsimi is approved to treat severely low blood sugar (hypoglycemia) in adults and children ages 4 years and older who have diabetes. It’s important to note that not treating this condition ...